1. Steward BW, Wild CP. World Cancer Report.

Lyon, France: International

Agency

2. Primul articol trimis de dna Cristina

3. Mateescu D, Bălăceanu A, Ciochinaru M, Vlad Ş, Livadariu D. Ghidul

pacientului oncologic. Bucureşti: Benett; 2010.
4. Marinca M, Miron L. Oncologie generală. 2 ed. Iaşi: ,,Gr.
T. Popa,, UMF Iaşi; 2012.
5. Oniga O, Eniu D, Tiperciuc B, Oniga I. Medicaţia anticanceroasă.
Actualităţi şi perspective. Cluj-Napoca: Editura Medicală Universitară ''Iuliu
Haţieganu''; 2014.
6. al doilea articol trimis de dna Cristina
7. Ferraz da Costa DC, Fialho E, Silva JL. Cancer Chemoprevention by
Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target.
Molecules. 2017;22
8. Ruţa F, Voidăzan TS. Epidemiologia bolilor canceroase. Târgu-Mureş:
Editura University Press; 2016.
9. Gavrilas LI, Ionescu C, Tudoran O, Lisencu C, Balacescu O, Miere D. The Role of Bioactive Dietary
Components in Modulating miRNA Expression in Colorectal Cancer. Nutrients. 2016;8(10).
10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782753/
11. http://www.bbc.co.uk/programmes/articles/4fc2VKWX4bDmDCnfmMNkbLB/how-can-i-avoid-
getting-cancer

5. global

2=4
6=8
7=9

Bibliografie: - micotoxine

1. Conf.dr. Carmen Solcan. Micotoxine, generalitati aflatoxinele

2. J. W. Bennett, M. Klich. Mycotoxins. Clinical Microbiology Reviews. 2003 July; 16(3): 497–516.
3. Regulamentul Uniunii Europene NR. 165/2010 al Comisiei din 26 februarie 2010 de modificare a
Regulamentului (CE) nr. 1881/2006 de stabilire a nivelurilor maxime pentru anumiti
contaminanti din produsele alimentare in ceea ce priveste aflatoxinele
4. Hui Chen Wu, Regina Santella. The Role of Aflatoxins in Hepatocellular Carcinoma Mon. 2012
October; 12 (10 HCC)
5. European Food Safety Authority. Aflatoxins in food
6. Oncologie generalã, ed. II, 2012, L. Miron, M. Marinica

Bibliografie ptaquilozida

1. M.J. Prival, in Encyclopedia of Food Sciences and Nutrition (Second Edition), 2003
 2. Roger W. Blowey BSc BVSC FRCVS FRAgS, A. David Weaver BSc DR MED VET PHD FRCVS, in Color
Atlas of Diseases and Disorders of Cattle (Third Edition), 2011

Alcaloizi cu pirolizidina
Hirono și colab., 1978).
(Ridker și colab., 1985; Weston și colab., 1987; Bach și colab., 1989; Ridker și McDermott 1989; Yeong și
colab., 1990)
Bibliografie

1. Adams WT, Skopek TR (1987) Statistical test for the comparison of samples from mutational
spectra. J Mol Biol 194: 391–396
2. Bach N, Thung SN, Schaffner F (1989) Comfrey herb tea-induced hepatic veno-occlusive
disease. Am J Med 87: 97–99
3. Betz JM, Eppley RM, Taylor WC, Andrzejewski D (1994) Determination of pyrrolizidine alkaloids in
commercial comfrey products (Symphytumsp.). J Pharm Sci 83: 649–653
4. Dycaico MJ, Provost GS, Kretz PL, Ransom SL, Moores JC, Short JM(1994) The use of shuttle
vectors for mutation analysis in transgenic mice and rats. Mutat Res 307: 461–478
5. FDA (2001) FDA advises dietary supplement manufacturers to remove comfrey products from
the market. USFDA, Center for Food Safety and Applied
Nutrition. http://vm.cfsan.fda.gov/~dms/dspltr06.html
6. Fu PP, Xia Q, Lin G, Chou MW (2004) Pyrrolizidine alkaloids – genotoxicity, metabolism enzymes,
metabolic activation, and mechanisms. Drug Metab Rev 36: 1–55

Macrocomponente

 Armstrong, B., and R. Doll. 1975. Environmental factors and cancer incidence and mortality in
different countries, with special reference to dietary practices. Int. J. Cancer 15: 617-631.
[PubMed]
 Berg, J. W. 1975. Can nutrition explain the pattern of international epidemiology of hormone-
dependent cancers? Cancer Res. 35: 3345-3350. [PubMed]
 de Waard, F. 1975. Breast cancer incidence and nutritional status with particular reference to
body weight and height. Cancer Res. 35: 3351-3356. [PubMed]
 de Waard, F., and E. A. Baanders-van Halewijn. 1974. A prospective study in general practice on
breast-cancer risk in postmenopausal women. Int. J. Cancer 14: 153-160. [PubMed]
 de Waard, F., J. P. Cornelis, K. Aoki, and M. Yoshida. 1977. Breast cancer incidence according to
weight and height in two cities of the Netherlands and in Aichi prefecture, Japan. Cancer 40:
1269-1275. [PubMed]
 Gaskill, S. P., W. L. McGuire, C. K. Osborne, and M. P. Stern. 1979. Breast cancer mortality and
diet in the United States. Cancer Res. 39: 3628-3637. [PubMed]
 Gregor, O., R. Toman, and F. Prušová. 1969. Gastrointestinal cancer and nutrition. Gut 10: 1031-
1034. [PMC free article] [PubMed]
 Hill, M., R. MacLennan, and K. Newcombe. 1979. Letter to the Editor: Diet and large-bowel
cancer in three socioeconomic groups in Hong Kong. Lancet 1: 436. [PubMed]
  Jain, M., G. M. Cook, F. G. Davis, M. G. Grace, G. R. Howe, and A. B. Miller. 1980. A case-control
study of diet and colo-rectal cancer. Int. J. Cancer 26: 757-768. [PubMed]
 Lavik, P. S., and C. A. Baumann. 1943. Further studies on the tumor-promoting action of
fat. Cancer Res. 3: 749-756.
 Lew, E. A., and L. Garfinkel. 1979. Variations in mortality by weight among 750,000 men and
women. J. Chronic Dis. 32: 563-576. [PubMed]
 Lin, T. M., K. P. Chen, and B. MacMahon. 1971. Epidemiologic characteristics of cancer of the
breast in Taiwan. Cancer 27: 1497-1504. [PubMed]
 MacMahon, B. 1975. Formal discussion of “Breast cancer incidence and nutritional status with
particular reference to body weight and height.” Cancer Res. 35: 3357-3358. [PubMed]
 Miller, A. B., A. Kelly, N. W. Choi, V. Matthews, R. W. Morgan, L. Munan, J. D.Burch, J. Feather, G.
R. Howe, and M. Jain. 1978. A study of diet and breast cancer. Am. J. Epidemiol. 107: 499-509.
[PubMed]
 Mirra, A. P., P. Cole, and B. MacMahon. 1971. Breast cancer in an area of high parity: São Paolo,
Brazil. Cancer Res. 31: 77-83. [PubMed]
 Tannenbaum, A. 1942. a. The genesis and growth of tumors. II. Effects of caloric restriction per
se. Cancer Res.2: 460-467.
 Tannenbaum, A. 1942. b. The genesis and growth of tumors. III. Effects of a high-fat diet. Cancer
Res. 2: 468-475.
 Tannenbaum, A. 1944. The dependence of the genesis of induced skin tumors on the caloric
intake during different stages of carcinogenesis. Cancer Res. 4: 673-677.
 Tannenbaum, A. 1945. a. The dependence of tumor formation on the degree of caloric
restriction. Cancer Res.5: 609-615.
 Tannenbaum, A. 1945. b. The dependence of tumor formation on the composition of the calorie-
restricted diet as well as on the degree of restriction. Cancer Res. 5: 616-625. [PubMed]
Zaharuri
http://www.mnwelldir.org/docs/nutrition/sugar.htm

Sare
References

1. ↑ Jump up to:1.0 1.1 Food Standards Australia and New Zealand. NUTTAB 2006 (Australian food
composition tables). FSANZ; 2006 Available from: http://web2.warilla-
h.schools.nsw.edu.au/text_books/pdhpe/PDHPE_in_Focus/yr11/online_book/resources/pdf/cha
pter_01/food_comp.pdf.
2. ↑ Jump up to:2.0 2.1 2.2 2.3 2.4 2.5 2.6 World Cancer Research Fund, American Institute for Cancer
Research. Food, nutrition, physical activity, and the prevention of cancer: a global
perspective. Washington DC: AICR; 2007.
3. ↑ Jump up to:3.0 3.1 3.2 3.3 National Heart Foundation of Australia. Position statement: the
relationships between dietary electrolytes and cardiovascular disease. Australia: NHFA; 2006
Available from: http://www.heartfoundation.org.au/SiteCollectionDocuments/Dietary-
Electrolytes-CVD-Position-Statement.pdf.
4. Jump up↑ Food Standards Australia and New Zealand. Consideration of mandatory fortification
with iodine for Australia and New Zealand: Dietary intake assessment report (main
report). FSANZ; 2008 Available
from: http://www.foodstandards.gov.au/code/proposals/documents/P1003%20SD10%20-
%20Dietary%20Intake%20Assessment.pdf.
5. Jump up↑ Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and
the prevention of cancer.Public Health Nutr 2004 Feb;7(1A):187-200 Abstract available
at http://www.ncbi.nlm.nih.gov/pubmed/14972060.
6. Jump up↑ Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic
evidence. Cancer Sci 2005 Jan;96(1):1-6 Abstract available
at http://www.ncbi.nlm.nih.gov/pubmed/15649247.
7. ↑ Jump up to:7.0 7.1 Ge S, Feng X, Shen L, Wei Z, Zhu Q, Sun J. Association between Habitual Dietary
Salt Intake and Risk of Gastric Cancer: A Systematic Review of Observational
Studies. Gastroenterol Res Pract 2012;2012:808120 Abstract available
at http://www.ncbi.nlm.nih.gov/pubmed/23125851.
8. ↑ Jump up to:8.0 8.1 8.2 D'Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and
risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr 2012 Aug;31(4):489-98
Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/22296873.
9. Jump up↑ World Health Organization, Food and Agriculture Organization. Diet, nutrition and the
prevention of chronic diseases. Geneva, Switzerland: WHO; 2003. Report No.: WHO technical
report series 916. Available
from: http://apps.who.int/iris/bitstream/10665/42665/1/WHO_TRS_916.pdf.
10. Jump up↑ World Cancer Research Fund, American Institute for Cancer Research. Policy and
action for cancer prevention. Food, nutrition, and physical activity: a global
perspective. Washington DC: AICR; 2009 Available
from: http://www.dietandcancerreport.org/cancer_resource_center/downloads/chapters/pr/Int
roductory%20pages.pdf.
11. ↑ Jump up to:11.0 11.1 11.2 Australian Institute of Health and Welfare. Cancer survival and prevalence in
Australia: period estimates from 1982 to 2010. Cancer Series no. 69. Cat. no. CAN 65. Canberra:
AIHW; 2012 Available from: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?
id=10737422721.
12. Jump up↑ Supramaniam R, O’Connell D, Tracey E, Sitas F. Cancer incidence in New South Wales
migrants 1991 to 2001.Sydney: Cancer Council NSW; 2006 Mar Available
from: http://www.cancercouncil.com.au/wp-content/uploads/2010/09/A-Pg-1-23-Intro.pdf.
13. Jump up↑ Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol
2003 Jan;56(1):1-9 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/12589864.
14. ↑ Jump up to:14.0 14.1 Australian Population Health Development Principal Committee (APHDPC). The
prevalence and severity of iodine deficiency in Australia. Australia: Health Ministers Advisory
Committee; 2007 Dec Available
from: http://www.foodstandards.gov.au/code/proposals/documents/The%20prevalence%20and
%20severity%20of%20iodine%20deficiency%20in%20Australia%2013%20Dec%202007.pdf.
15. Jump up↑ Stavrou EP, Baker DF, McElroy HJ, Bishop JF. Thyroid cancer in New South
Wales. Sydney: The Cancer Institute NSW; 2008.
16. ↑ Jump up to:16.0 16.1 16.2 Australian Bureau of Statistics. Australian Health Survey: Nutrition First
Results - Foods and Nutrients, 2011-12. Canberra: ABS; 2014 May 9. Report No.: 4364.0.55.007.
Available from: http://www.abs.gov.au/ausstats/abs@.nsf/mf/4364.0.55.007?OpenDocument.
17. Jump up↑ Australian Division of World Action on Salt and Health (AWASH). 2007 survey of
Australian consumer awareness and practices relating to salt. Sydney: The George Institute for
International Health; 2007 Available from: http://www.awash.org.au/wp-
content/uploads/2012/10/AWASH_ConsumerSurveyReport_2007_05_15.pdf.
18. ↑ Jump up to:18.0 18.1 National Health and Medical Research Council. Australian dietary
guidelines. Canberra: NHMRC; 2013 Available
 from: https://www.nhmrc.gov.au/_files_nhmrc/file/publications/n55_australian_dietary_guideli
nes1.pdf.
19. Jump up↑ National Health and Medical Research Council. Nutrient reference values for
Australia and New Zealand including recommended dietary intakes. Canberra: NHMRC; 2006
Available from: http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/n35.pdf.

Aditivi
Gheorghe Mencinicopschi, Biblia Alimentarã, Ed. Litera, București;
Elena Orãnescu, Aditivi Alimentari – Necesitate și risc, Agir, București, 2008

Preventive
Bibliografie
Oncologie generalã, ed. II, 2012, L. Miron, M. Marinica
Recomandări pentru tehnoredactarea lucrării de licenţă:

Formatul paginii : ISO B5 (176 x 250 mm),

Imprimarea lucrării se face față verso,

Margini pagină: interior 2 cm, sus și jos 2 cm, exterior 1,5 cm.

Numărul de pagini (exclusiv bibliografia): 50 pagini ± 10%,

Numerotarea paginilor se va face începând cu pagina de Cuprins până la ultima

pagină
a lucrării,

Cuprinsul începe pe pagina din dreapta,

Numărul paginii se trece în dreapta jos, pentru paginile impare și în stânga jos,
pentru cele pare,

Tip literă Times New Roman sau Arial,

Mărime litere: 14 pentru titluri, 12 pentru subtitluri și corpul textului,

Se utilizează diacritice,

Distanță între rânduri: 1,15 linii (cu excepţia tabelelor, unde este de 1 linie!),

Aliniatul: max. la 1.5 cm,

Opţiunea de aliniere a corpului textului este pe ambele margini (justified),

Figurile au un număr (cifre arabe) şi un titlu; se numerotează în ordinea apariţiei în

text,

Tabelele au un număr (cifre romane) şi un titlu; se numerotează în ordinea apariţiei

în text,

Capitolele încep întotdeauna pe pagina nouă,

Indicele bibliografic este inserat în text imediat după enunţarea faptului. Se poate
pune şi în mijlocul frazei, nefiind obligatoriu la sfârşitul ei,

Sistemul de scriere a bibliografiei agreat de Universitatea de Medicină şi Farmacie

„Iuliu Haţieganu” este sistemul Vancouver
Curs Metodologia cercetării, an IV, Facultatea de Farmaci